Americans are growing less confident in Trump's coronavirus response, poll shows
Approval ratings for the coronavirus response from President Trump and the Centers for Disease Control are dipping, a new poll released by Morning Consult on Monday shows.
Of those surveyed, 49 percent approved of the job Trump is doing to prepare the U.S. for the virus, which is down 7 percent from the previous week's poll and 12 percent from earlier this month. His disapproval rating, meanwhile, jumped up from 27 percent to 37 percent.
The CDC maintains a higher rating than the president, but it dropped 3 percent in Monday's poll. There was only a 1-point change in the agency's disapproval rating, however.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Morning Consult notes the decline is likely a result of news about local outbreaks in the country, which include multiple deaths, as well as reports about false negative tests.
The poll, conducted between Feb. 28 and March 1, surveyed 1,997 registered voters. The margin of error is two percentage points. Read more at Morning Consult.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Proposed Trump-Putin talks in Budapest on holdSpeed Read Trump apparently has no concrete plans to meet with Putin for Ukraine peace talks
-
Trump demands millions from his administrationSpeed Read The president has requested $230 million in compensation from the Justice Department for previous federal investigations
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
